Posted on 05/02/2020 2:52:04 PM PDT by weston
Q #4286 available
NY SUN: "The courts may decide only actual cases and controversies. When both sides desire to end their dispute, the power of the court to act is over."— Jack Posobiec (@JackPosobiec) May 19, 2020
4285
Link to New Q Drop
Q
!!Hs1Jq13jV6
19 May 2020 - 1:51:29 PM
https://www.bloomberg.com/news/articles/2020-02-05/china-is-trying-to-patent-gilead-s-experimental-coronavirus-drug
***************The good thing in having a patent is that it would lead to cross-licensing situations that give China more bargaining chips in negotiating the licensing fee with Gilead, said Wang Yanyu, a senior partner at AllBright Law Offices in Beijing.
While Gileads experimental drug isnt licensed or approved anywhere in the world, it is being rushed into trials in China on coronavirus patients after showing early signs of being highly effective. It may go into clinical trials in China as early as next week in patients with moderate and severe symptoms of the pathogen, said Merdad Parsey, Gileads chief medical officer.
https://www.gatesfoundation.org/Media-Center/Press-Releases/2010/12/Global-Health-Leaders-Launch-Decade-of-Vaccines-Collaboration
The Leadership Council is comprised of:
Dr. Margaret Chan, Director General of WHO;
Dr. Anthony S. Fauci, Director of NIAID, part of the National Institutes of Health;
Mr. Anthony Lake, Executive Director for UNICEF;
Ms. Joy Phumaphi, Chair of the International Advisory Committee and Executive Secretary, African Leaders Malaria Alliance
Dr. Tachi Yamada, President of Global Health at the Bill & Melinda Gates Foundation;
The Steering Committee includes globally recognized experts in vaccine delivery, advocacy, research and development, and access:
Dr. Nicole Bates, Senior Program Officer, Global Health Policy and Advocacy, Bill & Melinda Gates Foundation
Dr. Seth Berkley, President & CEO, International AIDS Vaccine Initiative (IAVI)
Dr. Zulfiqar Bhutta, Founding Chair, Division of Women and Child Health, Aga Khan University
Dr. Lola Dare, CEO, Center for Health Sciences Training, Research and Development International
Ms. Helen Evans, Acting CEO, GAVI Alliance
Dr. Lee Hall, Chief, Parasitology and International Programs Branch, Division of Microbiology and Infectious Diseases, NIAID
Dr. T. Jacob John, Professor and Head, Departments of Clinical Microbiology and Virology, Christian Medical College, Vellore, India (Retired)
Dr. Orin Levine, Executive Director, International Vaccine Access Center (IVAC)
Dr. Jean-Marie Okwo-Bele, Director, WHO Department of Immunization, Vaccines and Biologicals
Dr. Ciro de Quadros, Executive Vice President, Sabin Vaccine Institute
Dr. David Salisbury, Director of Immunization, UK Department of Health
Dr. Anne Schuchat, Director, National Center for Immunization and Respiratory Diseases, CDC
Dr. Peter A. Singer, Director, McLaughlin-Rotman Centre for Global Health, University of Toronto
Dr. Lucky Slamet, Deputy for Therapeutic Products, Narcotic, Psychotropic and Addictive Substance Control, National Agency of Drug and Food Control, Indonesia
Dr. Gina Tambini, Area Manager, Family and Community Health, PAHO
Dr. Jos Vandelaer, Chief, Immunization, Programme Division, UNICEF
Ms. Sandy Wrobel, CEO and Managing Director, Applied Strategies
https://gcgh.grandchallenges.org/about/scientific-board
Scientific Board
(2003-2010)
Harold Varmus, M.D., Chair of Board and Executive Committee
President and Chief Executive Officer
Memorial Sloan-Kettering Cancer Center
United States
Tadataka (Tachi) Yamada, M.D., Member, Executive Committee
President
Global Health Program
Bill & Melinda Gates Foundation
United States
Elias A. Zerhouni, M.D., Member, Executive Committee
Director, National Institutes of Health
U.S. Department of Health and Human Services
United States
Sir Roy Anderson, Ph.D., F.R.S., Member, Scientific Board
Professor and Head
Department of Infectious Disease Epidemiology
Imperial College of the University of London
United Kingdom
Alan Bernstein, O.C., Ph.D., F.R.S.C, Member, Scientific Board
Executive Director
Global HIV Vaccine Enterprise
United States
Mary Jane Cardosa, Ph.D., Member, Scientific Board
Professor of Virology
Institute of Health and Community Medicine
Universiti Malaysia Sarawak
Malaysia
Pierre Chartrand, Ph.D., Member, Scientific Board
Acting President of the Canadian Institutes of Health Research
Canadian Institutes of Health Research / Instituts de recherche en santé du Canada
Canada
Christine M. Debouck, Ph.D., Member, Scientific Board
Pharmaceutical & Biotechnology Consultant
United States
Anthony S. Fauci, M.D., Member, Scientific Board
Director
National Institute of Allergy and Infectious Diseases
National Institutes of Health
United States
William Foege, M.D., M.P.H., Member, Scientific Board
Senior Fellow
Global Health Program
Bill & Melinda Gates Foundation
United States
Nirmal Kumar Ganguly, M.D., Member, Scientific Board
Director General
Indian Council for Medical Research
India
Julie Louise Gerberding, M.D., M.P.H., Member, Scientific Board
Former Director, Centers for Disease Control and Prevention
Associate Professor of Medicine, University of California, San Francisco
Fotis C. Kafatos, Ph.D., Member, Scientific Board
Chair in Insect Immunogenetics
Department of Biological Sciences
Faculty of Life Sciences
Imperial College London
United Kingdom
Gerald T. Keusch, M.D., Member, Scientific Board
Assistant Provost for Global Health, Medical Campus
and Associate Dean for Global Health
Boston University
United States
Francis Kwesi Nkrumah, M.D., Ph.D., Member, Scientific Board
Former Director
Noguchi Memorial Institute for Medical Research
University of Ghana, ACCRA
Ghana
Sir Gustav Nossal, Ph.D., F.R.S., Member, Scientific Board
Department of Pathology
University Of Melbourne
Australia
Odile Puijalon, Ph.D., Member, Scientific Board
Chef de Laboratoire
Institut Pasteur
France
Yiming Shao, M.D., Ph.D., Member, Scientific Board
Chief Expert
National Center for AIDS/STD Control and Prevention
China
Peter A. Singer M.D., M.P.H., F.R.C.P.C., Member, Scientific Board
Senior Scientist, McLaughlin Centre for Molecular Medicine
Professor of Medicine, University of Toronto and University Health Network
Canada
Mark Walport, Ph.D.,MB. BChir., Member, Scientific Board
Director
The Wellcome Trust
United Kingdom
Florence Muringi Wambugu, Ph.D., Member, Scientific Board
President
A Harvest Biotech Foundation International(AHBFI)
Kenya
Yongyuth Yuthavong, Ph.D., Member, Scientific Board
Senior Scientist
National Science and Technology Development Agency
Thailand
Q
Wow, I didn’t realize she was down that much. Even half of that would be bad.
#4286
Link to New Q Drop
Q
!!Hs1Jq13jV6
19 May 2020 - 2:15:44 PM
https://www.youtube.com/channel/UCy5CvZAyn7skY1OCrg0VcYw
An audio recording of a conversation between Joe Biden and Petro Poroshenko on May 13, 2016
4.6K views
4 hours ago
1:57
NOW PLAYING
WATCH LATER
ADD TO QUEUE
An audio recording of a conversation between Joe Biden and Petro Poroshenko on March 22, 2016
1.2K views
4 hours ago
2:14
NOW PLAYING
An audio recording of a conversation between Joe Biden and Petro Poroshenko on February 18, 2016
1K views
4 hours ago
3:17
NOW PLAYING
An audio recording of a conversation between John Kerry and Petro Poroshenko on May 13, 2016
805 views
4 hours ago
2:46
NOW PLAYING
An audio recording of a conversation between Joe Biden and Petro Poroshenko on May 13, 2016
297 views
4 hours ago
Q
#4286...................((CONT.))
31:50
NOW PLAYING
WATCH LATER
ADD TO QUEUE
Facts of international corruption: Conversations between P. Poroshenko, J. Biden and J. Kerry
480 views
5 hours ago
11:41
NOW PLAYING
$1 billion of US taxpayers’ money in exchange for maintaining Burisma schemes
2.5K views
5 hours ago
Yelp. Becoming paranoid.
Heres POTUS note from his doctor. LOL
https://twitter.com/inthematrixxx/status/1262764592473583617?s=21
Get the rope ready!
Gonna take a nap. Shopping’s got me dropping!
BoumtjeBoumtje Medium starMedium starMedium star
Susan Rice testimony to Congress ... just sickening
GenFlynn
would’ve had US Intel laser focused on China. Instead we got 4 yrs of chasing Russian boogeymen & Ukraine Impeachment hoaxes
How many 10Ks US lives could’ve been saved & untold economic damage avoided?
https://intelligence.house.gov/uploadedfiles/sr44.pdf
Do you have a link to the original document this clip is taken from? Id love to see more. Thanks.
BoumtjeBoumtje
From her recently declassified closed door Russian Interference Investigate congressional testimony 3yrs ago that
RepAdamSchiff
was hiding.
Bottom of pg. 46 ... Top of pg. 47
Page-46
time and effort that my team put into trying to execute a responsible transition at
the direction of President Obama.
And so, when General Flynn was named to his role, we were actually in the
midst of the President’s last foreign trip to Greece, Germany, and Peru. As soon
as we returned from that trip, I reached out to try to introduce myself to General
Flynn and to congratulate him and to offer any and all support that we could
provide. I offered to make myself available for as many hours between that point
and January 20th as he found helpful or necessary. And l, frankly, found myself
chasing him to try to find time that worked on both of our schedules to provide that
handoff.
ln the course of the four meetings that I described, we touched on all the
major - major - policy issues that you might imagine. Obviously, Russia was
one of them. We touched, however, more superficially on Russia than might have
otherwise been the case. This was my judgment. We - he had all the briefing
materials provided to him on Russia, and those remain unchanged. We didn’t talk
about Ambassador Kislyak, to answer specifically your question, but we did talk
about Russia as an adversary, as a threat to NATO. We talked about Ukraine.
We talked about Syria. We talked about lran and Russia in al! of those contexts.
But, frankty, we spent a lot more time talking about China in part because
General Flynn’s focus was on China as our principal overarching adversary. He
had many questions and concems about China. And when I elicited - sought to
elicit his perspective on Russia, he was quite - I started to say dismissive, but that
may be an overstatement. He downplayed his assessment of Russia as a threat
to the United States. He called it overblown. He said they’re a declining power,
they’re demographically challenged, they’re not really much of a threat, and then
************************
Page 47
reemphasized the importance of China.
I had seen enough at that point and heard enough to be a little bit sensitive
to the question of the nature of General Flynn’s engagements with the Russians.
And so, while I certainly gave him what he - what I thought any incoming National
Security Advisor would need, in terms of broad strokes of Russia policy, Ukraine,
Syria, all of those things, I didn’t go into depth on particularly
in the sort of
hard national security realrn. lfigured that he could become briefed on that when
he took office.
MR. SCHIFF: And during those discussions, did he ever bring up his
meetings with or conversations with Ambassador Kislyak?
MS. RICE: He did not.
MR, SCHIFF: And you didn’t raise the subject with him, in light of what
Mr. Billingsly had told you?
MS. RICE: No, I don’t recallthat I did.
MR. SCHIFF: There have been public reports about Mr. Kushner also
meeting with Ambassador Kislyak and General Flynn and having discussions of
setting up a secret back channel at a Russian diplomatic facility. ls that
something you were aware of at the time?
MS. RICE: lt was not something I was aware of at the time.
MR. SCHIFF: Some have attempted to defend that as being a normal,
usual, or laudable practice to establish that kind of channel. What is your take on
the idea of setting up a secret channel through a Russian diplomatic facility?
MS. RICE: Quite frankly, when I read that report and to the extent that I
thought it might be true, lwas honified. lt’s inconceivable to me that someone
*********************************
Page 48
associated with an incoming administration would seek to have a private channel
with an adversarial government designed to be hidden from the govemment that
he or she was going to represent in a few weeks’ time.
And the fact that one would consider, if this is, in fact, the case - and I have
no independent knowledge of this - using Russian communications to speak to
Moscow is hair-raising.
MR. SCHIFF: And what about the Russian communications makes you
say that?
MS. RICE: That approach, if it’s true, would suggest to me that one places
more confidence in our principal adversary’s interests and communications than
they do in our own. And it is deeply troubling to me that anybody responsible in
any way, shape, or form for U.S. policy would privilege the Russians over the
United States Government.
MR. SCHIFF: Let me ask you about some of the chronology that you went
over with Mr. Gowdy. When you initially learned about the hacking, did this
appear like another intelligencegathering operation that is no different than other
instances in the past of a foreign govemment wanting to know information about a
potential candidate, someone who might become the President of the United
States?
MS. RICE: Obviously, we didn’t know. We were concerned to find out, as
best we could, but we’d had sufficient predicates and precedents of that sort of
intelligencegathering for informationgathering espionage purposes that we might
have at first blush had a hypothesis that that’s what this was.
MR. SCHIFF: Was it only in August that you learned that more than a
foreign intelligenceaathering operation, this was going to be an effort to use that
*************************
Page 49
data, to effectively weaponize it, to influence the outcome?
MS. RICE: I can’t be precise in saying that - thats when I recall it most
clearly; let me put it that way
I
I can’t say that we hadn’t - as I said,
MR. SCHIFF: One of the questions that we’ve been trying to answer - l’d
be interested in your perspective on it - is whether the Russian intention from the
beginning was to engage in an effort to influence the outcome or whether this
began as one thing, as a foreign intelligence-gathering operation, and later there
was some decision point made to utilize the data they had stolen. ln other words,
was it the Russian intention all along to gather the information for the purpose of
using it, or was there something that triggered a Russian decision to affirmatively
try to affect the outcome?
MS. RICE: I don’t have the ability, based on what I saw while I was in
government alone to make that judgment with confidence. I can tell you what I
now believe as a private citizen, aggregating what I knew while 1 was in
government with what I have leamed subsequently from public reporting, which I
acknowledge may not be entirely accurate.
But my impression, looking at the full span of this, is that the Russians
were — have been for years gathering information for information purposes from
U.S. entities of various sorts, governmentaland nongovernmental; that at some
*************
Page 50
stage, presumably in the spring of 2016 or early summer, they took a decision to
become more actively involved in our election process, through hacking, leaking,
and potentially - although I don’t know that we ever saw information suggesting
that they actually did this - falsifying information or manipulating our voting
system.
But, you know, somewhere along the line, I believe they took a decision to
do something more than simply gather information for intelligence purposes but to
involve themselves in our election affirmatively
MR. SCHIFF: lt was clear, I guess, in August that the Russian goalwas
going to be more extensive and involved than just gathering intelligence.
MS. RICE: lt was becoming clear.
I and lthink we had - we did not have a comprehensive assessment to that
effect. And there were, frankly, some agencies that were less invested in that
reporting than others.
MR. SCHIFF: At what point were you confident of the Russian attribution?
When would you peg that, in terms of the calendar? When did you feel that you
had enough confidence about the attribution to discuss it publicly?
MS. RICE:
MR. SCHIFF: And was there a discussion going on within the NSC about
public attribution, when it should be made, who it should be made by, and whether
there ought to be an effort made to impose sanctions at the time of attribution?
MS. RICE: So let me take those in parts because they’re not all one and
I’ve been paying bills online through my bank ever since a brilliant person came up with the idea. The only check I write is for my rent, and in California I had the bank send a check for rent. Actually now I do all my banking on my phone app.
But that password is the one I never forget.
“my smartest friend who is also anti-Trump”
Oxymoron?
The actor?
@SenateCloakroom
· 2h
Confirmed, 74-20: Executive Calendar #564 Scott H. Rash to be U.S. District Judge for the District of Arizona
You could also try getting a tape recorder and tape him while barking then play it back to him while he is barking. Not sure if this one works, but if not you could play it back at night so the people with the dog can get a taste of it.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.